Elder Scientists Are A Vast Resource: Let's Put Their Skills To Good Use

National Science Foundation statistics show that in 1986 there were 835,500 U.S. scientists and engineers who were 55 years of age or older and still employed. Surprisingly, there are no reliable statistics on the number of retired scientists and engineers, according to the American Association of Retired Persons. Despite this knowledge gap, it is reasonable to assume that many thousands of scientists are nearing or in retirement. This number will increase in line with the well-established de

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

National Science Foundation statistics show that in 1986 there were 835,500 U.S. scientists and engineers who were 55 years of age or older and still employed. Surprisingly, there are no reliable statistics on the number of retired scientists and engineers, according to the American Association of Retired Persons.

Despite this knowledge gap, it is reasonable to assume that many thousands of scientists are nearing or in retirement. This number will increase in line with the well-established demographic trend of an aging workforce in the U.S.

Elder scientists, like elder statesmen, offer many opportunities for society to benefit from their experience and wisdom. Yet we tend to ignore the role they could play in the vitality of our nation'a educational, scientific, and economic enterpises. It is time to ask how the varied talents of elder scientists might best be applied.

Retired scientists could, for instance, alleviate the already acute shortage of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies